Part of you is concerned — after all, you know depression can be serious — but on the other hand, can’t weight loss be a good ...

Obesity can put strain on the heart, resulting in an increased risk of conditions such as atrial fibrillation, or irregular ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

She was the classic case of being skinny fat, a person who has normal body weight but has a high percentage of body fat ...

TUESDAY, Jan. 21, 2025 (HealthDay News) -- Black people with obesity are less likely to get weight-loss surgery than others.

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

With President Donald Trump back in the White House, several American doctors are welcoming the new administration’s greater ...

Obesity is a global public health problem, with rates steadily increasing in many regions of the world. However, the impact ...

Adding time-restricted eating to usual care didn't offer extra benefits in reducing visceral fat but lowered subcutaneous fat ...

A study analyzing data from over 2 million veterans found that GLP-1 receptor agonists, popular weight-loss drugs like Ozempic and Wegovy, provide significant neurological and behavioral health ...

Insights from a study on GLP-1 receptor agonists reveal benefits for cardiometabolic health, with notable risks for ...